Charles Wayland

Chuck brings more than 25 years of experience to the laboratory and medical diagnostics industries. Since joining Metabolon in 2018, Chuck has restructured the North American sales organization to align with selling larger contracts in the commercial markets. Before joining Metabolon, Chuck led North American sales organizations for Progenity and QIAGEN. He has a proven history of driving successful teams in large and smaller-scale environments, with revenue responsibility of up to $480M, and sales organizations of 120 team members. He holds a Bachelor of Science in Management from Texas Tech University.